The results showed that COX-2 inhibition blocked VEGF productions in some HNSCC cells; in contrast, other COX-2 (and PGE2) expressing HNSCC cells showed little response to COX-2 inhibition, this effect depending upon a differential expression of COX-1. The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.